1. Home
  2. RXT vs ALVO Comparison

RXT vs ALVO Comparison

Compare RXT & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rackspace Technology Inc.

RXT

Rackspace Technology Inc.

HOLD

Current Price

$4.09

Market Cap

968.5M

Sector

Technology

ML Signal

HOLD

Logo Alvotech

ALVO

Alvotech

HOLD

Current Price

$5.78

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RXT
ALVO
Founded
1998
2013
Country
United States
Luxembourg
Employees
5000
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
968.5M
1.0B
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
RXT
ALVO
Price
$4.09
$5.78
Analyst Decision
Hold
Buy
Analyst Count
6
4
Target Price
$1.71
$8.00
AVG Volume (30 Days)
6.2M
1.0M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
75.13
N/A
EPS
N/A
N/A
Revenue
$2,685,700,000.00
N/A
Revenue This Year
N/A
$13.28
Revenue Next Year
$1.35
$18.63
P/E Ratio
N/A
$18.20
Revenue Growth
N/A
N/A
52 Week Low
$0.39
$2.94
52 Week High
$8.60
$9.05

Technical Indicators

Market Signals
Indicator
RXT
ALVO
Relative Strength Index (RSI) 59.20 N/A
Support Level $4.02 N/A
Resistance Level $5.67 N/A
Average True Range (ATR) 0.26 0.00
MACD 0.15 0.00
Stochastic Oscillator 82.81 0.00

Price Performance

Historical Comparison
RXT
ALVO

About RXT Rackspace Technology Inc.

Rackspace Technology Inc is an end-to-end, hybrid, multi-cloud technology services company. It designs, builds, and operates its customers' cloud environments across all technology platforms, irrespective of technology stack or deployment model. The company's solutions include Application Services, Data, Colocation, Cloud, Managed Hosting, Professional Services, and Security and Compliance. It has two reportable segments: Private Cloud and Public Cloud. Maximum revenue is generated from the Public Cloud segment, which offers cloud solutions through managed services, elastic engineering, and professional services offerings for customer environments hosted on the AWS, Microsoft Azure, and Google Cloud public cloud platforms. Geographically, the company derives its key revenue from the U.S.

About ALVO Alvotech

Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.

Share on Social Networks: